CYP19A1 and Hypergonadotropic hypogonadism: Common ways of increasing intra-testicular testosterone levels in men with NOA and hypergonadotrophic hypogonadism are by use of aromatase inhibitors (steroidal and non-steroidal) and anti-oestrogens.